Boston Scientific Device Linked to Reduced Stroke Risk: Study

Patients with irregular heart rhythm who are unable to take the standard therapy of warfarin experienced reduced risk of stroke following treatment with a device marketed by Boston Scientific.
The Wall Street Journal